A detailed history of Kbc Group Nv transactions in Pfizer Inc stock. As of the latest transaction made, Kbc Group Nv holds 10,042,627 shares of PFE stock, worth $281 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
10,042,627
Previous 4,376,037 129.49%
Holding current value
$281 Million
Previous $126 Million 121.2%
% of portfolio
0.89%
Previous 0.45%

Shares

42 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$25.89 - $29.73 $147 Million - $168 Million
5,666,590 Added 129.49%
10,042,627 $279 Million
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $36.7 Million - $47.7 Million
1,405,842 Added 47.33%
4,376,037 $126 Million
Q3 2023

Feb 15, 2024

BUY
$32.09 - $37.51 $4.64 Million - $5.42 Million
144,522 Added 4.84%
3,129,268 $104 Million
Q2 2023

Feb 15, 2024

SELL
$36.12 - $41.79 $41 Million - $47.5 Million
-1,136,220 Reduced 27.57%
2,984,746 $109 Million
Q2 2023

Jul 28, 2023

SELL
$36.12 - $41.79 $26.3 Million - $30.4 Million
-727,663 Reduced 19.68%
2,970,195 $109 Million
Q1 2023

Feb 14, 2024

SELL
$39.39 - $51.28 $7.55 Million - $9.83 Million
-191,774 Reduced 4.91%
3,714,770 $152 Million
Q1 2023

May 04, 2023

SELL
$39.39 - $51.28 $16.2 Million - $21.1 Million
-411,077 Reduced 10.0%
3,697,858 $151 Million
Q4 2022

Feb 14, 2024

SELL
$41.75 - $54.5 $6.54 Million - $8.54 Million
-156,618 Reduced 3.85%
3,906,544 $200 Million
Q3 2022

Feb 15, 2024

SELL
$43.76 - $53.42 $11.2 Million - $13.6 Million
-255,071 Reduced 5.83%
4,120,966 $180 Million
Q3 2022

Nov 08, 2022

BUY
$43.76 - $53.42 $3.25 Million - $3.97 Million
74,362 Added 1.84%
4,108,935 $180 Million
Q2 2022

Feb 14, 2024

BUY
$46.53 - $55.17 $31.3 Million - $37.1 Million
671,884 Added 19.81%
4,063,162 $213 Million
Q2 2022

Jul 26, 2022

BUY
$46.53 - $55.17 $29.9 Million - $35.5 Million
643,295 Added 18.97%
4,034,573 $212 Million
Q1 2022

Feb 14, 2024

BUY
$45.75 - $56.69 $27 Million - $33.5 Million
591,086 Added 21.11%
3,391,278 $176 Million
Q1 2022

May 06, 2022

BUY
$45.75 - $56.69 $27 Million - $33.5 Million
591,086 Added 21.11%
3,391,278 $176 Million
Q4 2021

Feb 14, 2024

SELL
$41.32 - $61.25 $65.1 Million - $96.5 Million
-1,575,845 Reduced 36.01%
2,800,192 $165 Million
Q4 2021

Feb 03, 2022

BUY
$41.32 - $61.25 $31.6 Million - $46.8 Million
764,806 Added 37.58%
2,800,192 $165 Million
Q3 2021

Nov 10, 2021

BUY
$39.25 - $50.42 $17.1 Million - $21.9 Million
434,801 Added 27.17%
2,035,386 $87.5 Million
Q2 2021

Aug 11, 2021

BUY
$35.91 - $40.68 $9.36 Million - $10.6 Million
260,736 Added 19.46%
1,600,585 $62.7 Million
Q1 2021

Apr 26, 2021

BUY
$33.49 - $37.77 $7.29 Million - $8.22 Million
217,588 Added 19.39%
1,339,849 $48.5 Million
Q4 2020

Feb 10, 2021

SELL
$33.47 - $42.56 $4.75 Million - $6.04 Million
-141,818 Reduced 11.22%
1,122,261 $41.3 Million
Q3 2020

Oct 28, 2020

SELL
$31.75 - $37.25 $53.7 Million - $63 Million
-1,691,378 Reduced 57.23%
1,264,079 $46.4 Million
Q2 2020

Aug 10, 2020

SELL
$30.12 - $36.54 $2.29 Million - $2.78 Million
-76,041 Reduced 2.51%
2,955,457 $96.6 Million
Q1 2020

May 04, 2020

BUY
$27.03 - $38.62 $13.8 Million - $19.7 Million
509,998 Added 20.23%
3,031,498 $98.9 Million
Q4 2019

Feb 11, 2020

SELL
$32.92 - $37.36 $47.4 Million - $53.7 Million
-1,438,535 Reduced 36.33%
2,521,500 $98.8 Million
Q3 2019

Nov 07, 2019

BUY
$32.49 - $42.13 $128 Million - $166 Million
3,951,190 Added 44671.45%
3,960,035 $135 Million
Q2 2019

Dec 03, 2019

SELL
$36.98 - $41.52 $135 Million - $152 Million
-3,655,813 Reduced 99.76%
8,845 $383,000
Q2 2019

Jul 30, 2019

BUY
$36.98 - $41.52 $135 Million - $152 Million
3,655,813 Added 41331.97%
3,664,658 $0
Q1 2019

Dec 03, 2019

SELL
$37.5 - $41.2 $149 Million - $163 Million
-3,961,318 Reduced 99.78%
8,845 $376,000
Q1 2019

May 10, 2019

BUY
$37.5 - $41.2 $148 Million - $163 Million
3,958,998 Added 35459.01%
3,970,163 $0
Q4 2018

Dec 03, 2019

SELL
$38.47 - $43.86 $149 Million - $170 Million
-3,879,133 Reduced 99.71%
11,165 $487,000
Q4 2018

Jan 31, 2019

BUY
$38.47 - $43.86 $149 Million - $170 Million
3,878,983 Added 34281.78%
3,890,298 $161 Million
Q3 2018

Dec 03, 2019

SELL
$34.47 - $41.81 $134 Million - $163 Million
-3,893,546 Reduced 99.71%
11,315 $499,000
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $134 Million - $163 Million
3,893,546 Added 34410.48%
3,904,861 $0
Q2 2018

Dec 03, 2019

SELL
$32.98 - $35.16 $113 Million - $120 Million
-3,423,962 Reduced 99.67%
11,315 $411,000
Q2 2018

Aug 03, 2018

BUY
$32.98 - $35.16 $113 Million - $120 Million
3,423,962 Added 30260.38%
3,435,277 $0
Q1 2018

Dec 03, 2019

SELL
$31.91 - $37.02 $116 Million - $134 Million
-3,631,498 Reduced 99.69%
11,315 $402,000
Q1 2018

May 09, 2018

BUY
$31.91 - $37.02 $116 Million - $134 Million
3,631,498 Added 32094.55%
3,642,813 $0
Q4 2017

Dec 03, 2019

SELL
$33.26 - $35.29 $103 Million - $109 Million
-3,083,029 Reduced 99.63%
11,315 $410,000
Q4 2017

Feb 07, 2018

BUY
$33.26 - $35.29 $103 Million - $109 Million
3,083,029 Added 27247.27%
3,094,344 $0
Q3 2017

Dec 03, 2019

SELL
$31.0 - $34.15 $102 Million - $112 Million
-3,285,253 Reduced 99.66%
11,315 $404,000
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $102 Million - $112 Million
3,285,253 Added 29034.49%
3,296,568 $0
Q2 2017

Dec 03, 2019

BUY
N/A
11,315
11,315 $380,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.